1,171 results on '"Carcinoma -- Care and treatment"'
Search Results
1152. Diagnosis and management strategies for Merkel cell carcinoma of skin described
1153. Diagnosis and management strategies for Merkel cell carcinoma of skin described
1154. Diagnosis and management strategies for Merkel cell carcinoma of skin described
1155. EBER expression of urinary bladder carcinoma detected in two Asian patients
1156. EBER expression of urinary bladder carcinoma detected in two Asian patients
1157. EBER expression of urinary bladder carcinoma detected in two Asian patients
1158. Efficacy of chemotherapy for treating two subsets of unknown primary carcinoma
1159. Treatment options in hormone-refractory metastatic prostate carcinoma reviewed
1160. Doxorubicin + Cisplatin vs Doxorubicin + 24-h Paclitaxel + Filgrastim in Endometrial Carcinoma
1161. Ovarian Carcinoma Treated with High-Dose Chemotherapy and Autologous Stem Cell Transplantation
1162. Bayer and Onyx get Fast Track for BAY 43-9006
1163. Uterine Papillary Serous Carcinoma: Comparisons of Outcomes in Surgical Stage I Patients With and Without Adjuvant Therapy
1164. Anti-HER2 Antibody, Trastuzumab in Patients with Recurrent or Refractory Ovarian or Primary Peritoneal Carcinoma with Overexpression of HER2
1165. Gemcitabine Activity in Nasopoharyngeal Carcinoma
1166. Intraperitoneal Chemotherapy for Ovarian Carcinoma
1167. Controversy Revisited: The Role for Nephrectomy in Metastatic Renal-Cell Carcinoma
1168. Sequential Combination Chemotherapy in Patients with Advanced Nonsmall Cell Lung Carcinoma
1169. Paclitaxel and High-Dose Oral Estramustine in Patients with Hormone-Refractory Prostate Carcinoma
1170. Treatment of Elderly Patients with Small Cell Carcinoma of the Lung
1171. Research conducted at People's Hospital, Department of Radiation Oncology has provided new information about nasopharyngeal carcinoma quality of care
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.